SMARCB1 is required for widespread BAF complex–mediated activation of enhancers and bivalent promoters
Robert Nakayama(Keio University), Cigall Kadoch(Broad Institute), Christina Williamson(Harvard University), Christian J. Widmer(Harvard University), George D. Demetri(American Society of Clinical Oncology), Wai Lim Ku(National Institutes of Health), Jeffrey A. Ranish(Institute for Systems Biology), Keji Zhao(National Heart Lung and Blood Institute), Mingxiang Teng(Dana-Farber Cancer Institute), Rafael A. Irizarry(Johns Hopkins University), Matthew J. McBride(Broad Institute), Alfredo M. Valencia(Broad Institute), Mark A. Gillespie(Western Norway University of Applied Sciences), Zachary M. McKenzie(Harvard University), He Qing(Harvard University), Seth H. Cassel(Broad Institute), Kairong Cui(National Institutes of Health), John L. Pulice(Broad Institute)
Cited by 296
Related Papers
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
A framework for oligonucleotide microarray preprocessing
|Bioinformatics|2010|1.6k
Accounting for cellular heterogeneity is critical in epigenome-wide association studies
|Genome biology|2014|1.2k
Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
|Nature Communications|2017|1k